Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
04/2010
04/14/2010CN1360592B Streptogramin derivs., production thereof and composition containing same
04/13/2010US7696195 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
04/13/2010US7695930 Method for the detection, identification and/or quantification of microoganisms with peptidase activity using phenoxazinone derivatives as enzyme substrates
04/13/2010CA2432303C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2422377C Pyrazole compounds useful as protein kinase inhibitors
04/08/2010WO2010040020A1 Methods of treating hepatic encephalopathy
04/08/2010WO2010037225A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/08/2010US20100087429 Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use
04/08/2010US20100087424 Tricyclic nitrogen containing heterocycles as antibacterial agents
04/08/2010US20100087326 Heterocylic compounds containing the morpholine nucleus their preparation and use
04/08/2010DE19820157B4 Neue Verbindungen auf Basis von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen New connections based on polyalkyl-1-oxa-diazaspirodecan connections
04/08/2010CA2739436A1 Methods of treating hepatic encephalopathy
04/08/2010CA2738348A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/07/2010EP2170904A1 Process for preparing amorphous rifaximin and the amorphous rifaximin thus obtained
04/07/2010EP2170807A1 Spiro compounds useful as antagonists of the h1 receptor
04/07/2010EP2007771B1 Imidazo compounds
04/07/2010EP1590340B1 Inhibitors of histone deacetylase
04/06/2010US7691857 3-Benzyl-3a-cyclobutyl-7-methoxymethyl-2-oxo-octahydro-oxazolo[4,5-c]pyridin-5-ium; useful as agents for stimulating the cognitive functions of the brain
04/06/2010US7691853 Pyrazole compounds useful as protein kinase inhibitors
04/06/2010US7691851 increased potency and selectivity in relation to currently known MMP-13 inhibitors; treating rheumatoid arthritis, osteoarthritis or inflammation; modified benzoxazine moiety
04/06/2010US7691840 Analogs of benzoquinone-containing ansamycins and methods of use thereof
04/06/2010CA2566108C Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
04/01/2010WO2010036921A2 Slow release of organoboronic acids in cross-coupling reactions
04/01/2010WO2010036871A1 Macrocyclic compounds as hepatitis c virus inhibitors
04/01/2010WO2010036551A1 Hepatitis c virus inhibitors
04/01/2010WO2010034740A1 (r)-3-(n,n-dimethylamino)pyrrolidine derivatives
04/01/2010WO2010034656A1 Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine d3 receptors
04/01/2010WO2010034243A1 Novel gene cluster
04/01/2010US20100081682 39-Desmethoxy Derivatives of Rapamycin
04/01/2010US20100081654 Oncogenic-RAS-signal dependent lethal compounds
04/01/2010US20100081650 Antimicrobial Compounds
04/01/2010US20100080771 Hepatitis C Virus Inhibitors
04/01/2010US20100080770 Hepatitis C Virus Inhibitors
04/01/2010CA2737252A1 Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors
03/2010
03/31/2010EP2168972A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity
03/31/2010EP2167508A1 Compounds for treating duchenne muscular dystrophy
03/31/2010EP2167494A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
03/31/2010EP2167484A2 Condensed anthranilamide insecticides
03/31/2010EP2166846A1 Inhibitors of janus kinases
03/31/2010CN101687884A macrolactone derivatives
03/31/2010CN101687871A Spiro condensed barbituric acid derivatives for use as antibacterial
03/31/2010CN101687861A Pyrazoles useful in the treatment of inflammation
03/30/2010US7687627 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
03/25/2010WO2010031251A1 Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof
03/25/2010WO2010008777A3 Fused azabicyclic pyridines
03/25/2010US20100075994 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
03/25/2010CA2737355A1 Rapalogs, pharmaceutical compositions, preparation methods and uses thereof
03/24/2010EP1615699B1 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
03/24/2010CN101679455A New progesterone receptor modulators
03/24/2010CN101679454A Antimicrobial heterocyclic compounds for treatment of bacterial infections
03/24/2010CN101679453A New process for preparing 3-methyl-4-phenylisoxazolo[3,4-d]pyridazin-7(6H)-one
03/24/2010CN101679405A 2-aminopyridine analogs as glucokinase activators
03/24/2010CN101679401A 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as MET kinase inhibitors for the treatment of tumors
03/24/2010CN101679348A 5-pyridinone substituted indazoles
03/24/2010CN101679339A Method for manufacturing neuraminic acid derivatives
03/24/2010CN101679257A Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
03/24/2010CN101676291A Rapamycin carbonate analog, pharmaceutical composition thereof, and preparation method and uses thereof
03/24/2010CN101676290A Levofloxacin salt, and preparation method thereof and medicament composition
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010US7683056 Pyridine derivatives and their use in the treatment of psychotic disorders
03/23/2010US7682387 Drug-delivery endovascular stent and method for treating restenosis
03/23/2010CA2460177C 3-substituted-4-pyrimidone derivatives
03/18/2010WO2010030954A1 Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
03/18/2010WO2010029379A1 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
03/18/2010WO2010003133A3 Cdk modulators
03/18/2010WO2009126806A3 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase
03/18/2010US20100069424 3-cyano-quinoline derivatives with antiproliferative activity
03/18/2010US20100069376 5-hydroxymethyl-oxazolidin-2-one antibacterials
03/18/2010US20100069374 Tricyclic benzopyrane compound
03/18/2010US20100069360 Organic compounds
03/18/2010CA2736130A1 Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
03/17/2010EP1948666B1 Hiv integrase inhibitors
03/17/2010CN101675060A Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
03/17/2010CN101675044A Epoxy compound and method for manufacturing the same
03/16/2010US7678903 Preparation of levofloxacin hemihydrate free of levofloxacin monohydrate by reacting (S)-(-) 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4] benzoxazine-6-carboxylic acid with N-methyl piperazine to yield crude levofloxacin which is suspended in isopropanol, adding water, precipitating
03/16/2010US7678901 Rapamycin analogs containing an antioxidant moiety
03/16/2010US7678802 Voltage gated sodium and calcium channel inhibitors
03/16/2010US7678791 4-Deoxy-3,4-[2-spiro-[1-[2-(2-methyl-5-nitro-imidazol-1-yl)ethyl]-piperidin-4-yl]]-(1H)-imidazo-(2,5-dihydro)rifamycin; antibiotic resistance; synergistic effects of covalently linking antibacterial pharmacophores together; pharmacokinetics; aerobic, anaerobic gram-positive and gram-negative bacteria
03/16/2010CA2512683C Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
03/11/2010WO2010028232A1 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
03/11/2010WO2010028116A1 Macrocyclics pyrimidines as aurora kinase inhibitors
03/11/2010WO2010027567A2 Tricyclic spirocycle derivatives and methods of use thereof
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010US20100063041 Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same
03/11/2010US20100061982 3-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
03/11/2010CA2736195A1 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
03/11/2010CA2735775A1 6-substituted benzoxazines
03/11/2010CA2735420A1 Macrocyclic pyrimidines as protein kinase inhibitors
03/10/2010EP2161275A1 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
03/10/2010EP2161239A1 Semiconductor nanocrystals
03/10/2010CN101665498A Organic compounds
03/04/2010US20100056605 Oxidative degradation products of atorvastatin calcium
03/04/2010US20100056509 Heteroaryl sulfonamides and ccr2
03/04/2010US20100056502 Compounds
03/03/2010EP2159216A1 Ih - Modulators
03/03/2010CN101659669A Method for preparing levofloxacin
03/02/2010US7671079 Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
03/02/2010US7671068 N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors
02/2010
02/25/2010WO2010020548A1 Glyt1 receptor antagonists
02/25/2010WO2004092124A8 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 220